Treatment outcome of tuberculosis patients diagnosed with human immunodeficiency virus infection in Iran.
Tabarsi
Payam
P
Mycobacteriology Research Center, NRITLD Massih Daneshvari Hospital, Darabad, Niavaran, Tehran, Iran. tabarsi@nritld.ac.ir
Baghaei
Parvaneh
P
Mirsaeidi
Mehdi
M
Amiri
Majid
M
Alipanah
Narges
N
Emami
Habib
H
Novin
Atieh
A
Mansouri
Davood
D
Masjedi
Mohammad R
MR
Velayati
Ali A
AA
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000453:epidemiology; D000328:Adult; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D016009:Chi-Square Distribution; D005260:Female; D006801:Humans; D007492:Iran / Q000453:epidemiology; D008297:Male; D017828:Rifabutin / Q000627:therapeutic use*; D015996:Survival Rate; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy* / Q000453:epidemiology
D000904:Antibiotics, Antitubercular; D017828:Rifabutin